When does MYMD PHARMACEUTICALS INC (MYMD) report earnings?
MYMD PHARMACEUTICALS INC (MYMD) will report earnings on 2024-08-12, after the market close.
MYMD PHARMACEUTICALS INC (MYMD) Forecast, Price Target & Analyst Ratings
NASDAQ:MYMD • US62856X2018
Current stock price
1.82 USD
0 (0%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MYMD PHARMACEUTICALS INC (MYMD).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $1.82 to mean target of $0.00, Based on 7 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
MYMD was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MYMD.
In the previous month the buy percentage consensus was at a similar level.
MYMD was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 12, 2024
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.96M 39.62% | 3.35M 13.18% | 1.67M -50.15% | N/A -100.00% | N/A | N/A | N/A | |
| EBITDA YoY % growth | -3.04M 65.88% | -6.36M -109.21% | -8.32M -30.82% | N/A 60.10% | N/A -269.28% | N/A -134.91% | N/A | |
| EBIT YoY % growth | -3.33M 63.84% | -6.61M -98.50% | -8.55M -29.35% | N/A 60.35% | N/A -262.54% | N/A -134.34% | N/A 46.94% | |
| Operating Margin | -112.50% | -197.31% | -511.98% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A 100.00% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A